Clinical Research of Rock Hill — Rock Hill, South Carolina

Clinical Research of Rock Hill is a clinical research site located in Rock Hill, South Carolina, United States 29732.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Research of Rock Hill has participated in 41 clinical trials with 15 currently active.

Therapeutic areas: Chronic Obstructive Pulmonary Disease, Moderate to Severe Chronic Obstructive Pulmonary Disease, Chronic Cough.

Sponsors: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA, Pfizer, Shionogi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rock Hill

Browse all research sites in South Carolina · View every site in Rock Hill

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research of Rock Hill?

Clinical Research of Rock Hill has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research of Rock Hill conducted?

Clinical Research of Rock Hill has 41 clinical trials on record, with 15 currently active. Their work covers Chronic Obstructive Pulmonary Disease, Moderate to Severe Chronic Obstructive Pulmonary Disease, Chronic Cough.

Is Clinical Research of Rock Hill accredited by Crixeo Clinical Trials?

Clinical Research of Rock Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research of Rock Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.